**Author details**

Aqsa Ullah1 , Mays Alani1 , Omar Chaudry2 , Afra Janarious3 , Nina Tsakadze4,5, Michele Nunes1 , Umesh Sharma5,6, Lourdes Benes-Lima7 , Elisa Marie Rossi8 , Carlyn Rodriguez-Nazario7 and Fabian Rossi5,9\*

1 Neurology Resident, Osceola Medical Center, Orlando, Florida, USA

2 Medical Student, Windsor University School of Medicine, Caribbean Medical School, St. Kitts, West Indies

3 Neurology Staff, University of Central Florida College of Medicine/HCA GME Consortium of Greater Orlando, Florida, USA

4 Director Headache Center Orlando VA Medical Center, Florida, USA

5 UCF Associate Professor of Neurology at UCF Medical School, Orlando, Florida, USA

6 Director Epileptic Center, Orlando VA Medical Center, USA

7 Neurology Staff, Orlando VA Medical Center, Orlando, Florida, USA

8 Research Coordinator Orlando VA Medical Center, Orlando, Florida, USA

9 Director Clinical Neurophysiology Laboratory, Orlando VA Medical Center, Orlando, Florida, USA

\*Address all correspondence to: fabian.rossi@va.gov

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**67**

jnnp-2014-310055

*The Relationship between Amyotrophic Lateral Sclerosis and Parkinson's Disease and Sleep…*

700-708.

10.1055/s-2005-864205.

[9] Boentert M, Glatz C, Helmle C, Okegwo A, Young P. Prevalence of sleep apnoea and capnographic detection of

amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. (2018); 89:418- 424. doi:10.1136/jnnp-2017-316515

[10] Santos C, Braghiroli A, Mazzini L, Pratesi R, Oliveira LV, Mora G. Sleeprelated breathing disorders in

amyotrophic lateral sclerosis. Monaldi Arch Chest Dis. (2003); 59:160-165.

[11] Culebras, A. Sleep Disorders and Neuromuscular Disease. Seminars in

[12] Boentert M. Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives. Nature and science of sleep (2019); 11: 97-111

[13] Won, C. H., & Kryger, M. Sleep in Patients with Restrictive Lung Disease. Clinics in Chest Medicine, (2014); 35: 505-512. doi: 10.1016/j.ccm.2014.06.006

[15] Aboussouan, L. S. Sleep-disordered Breathing in Neuromuscular Disease. American Journal of Respiratory and

[14] Berger KIRDM, Ayappa I, Goldring RM. Pathophysiology of hypoventilation during sleep. Sleep Med Clin. 2014; 9: 289-300. doi:10.1016/j.

jsmc.2014.05.014

Neurology (2005). doi: 10.1055/s-2005-867071

nocturnal hypoventilation in

[7] Panda S, Gourie-Davi M, Sharma A. Sleep disorders in amyotrophic lateral sclerosis: a questionnaire-based study from India. Neurol India (2018); 66:

[8] Perrin, C., Dambrosio, C., White, A., & Hill, N. S. Sleep in Restrictive and Neuromuscular Respiratory Disorders. Seminars in Respiratory and Critical Care Medicine. (2005); 26:117-130. doi:

*DOI: http://dx.doi.org/10.5772/intechopen.98934*

Neuromuscular Disease. Seminars in Neurology. (2009); 29: 429-437. doi:

Windebank, A., Staff, N. P., Maragakis, N. J., Berg, L. H., Genge, A., Miller, R., Baloh, R. H., Kern, R., Gothelf, Y., Lebovits, C., & Cudkowicz, M. Addressing heterogeneity in

amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle & Nerve (2020); https://doi.org/10.1002/mus.26801

[1] Nicolle, M. W. Sleep and

[2] Goyal, N. A., Berry, J. D.,

[3] Fermin, A. M., Afzal, U., & Culebras, A. Sleep in Neuromuscular Diseases. Sleep Medicine Clinics. (2016); 11: 53-64. doi: 10.1016/j.

[4] Brown RH, Al-Chalabi M.

Sclerosis and Frontotemporal Degeneration (2014);15: 610-617. https://doi.org/10.3109/21678421.2

[6] Berlowitz, D. J., Howard, M. E., Fiore, J. F., Hoorn, S. V., O'Donoghue, F. J., Westlake, J., Smith, A., Beer, F., Mathers, S., & Talman, P. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. Journal of Neurology, Neurosurgery & Psychiatry. (2015); 87: 280-286. https://doi.org/10.1136/

Amyotrophic lateral sclerosis. The New England Journal of Medicine (2017);

[5] Abe, K., Itoyama, Y., Sobue, G., Tsuji, S., Aoki, M., Doyu, M., Hamada, C., Kondo, K., Yoneoka, T., Akimoto, M., Yoshino, H., & Group, on behalf of T. E. A. S. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotrophic Lateral

jsmc.2015.10.005

377: 162-172.

014.959024

10.1055/s-0029-1237119

**References**

*The Relationship between Amyotrophic Lateral Sclerosis and Parkinson's Disease and Sleep… DOI: http://dx.doi.org/10.5772/intechopen.98934*
